Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

ResMed Stock: Is RMD Underperforming the Healthcare Sector?

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. Valued at $31.5 billion, the company operates in two segments: Sleep and Breathing Health, and Residential Care Software.

Companies with a market cap of $10 billion or more are typically called “large-cap stocks.” RMD fits squarely into that category, with a market cap above this threshold that reflects its substantial size and influence in the medical instruments and supplies industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.